Mandal Palash Kumar, Adhikari Anindya, De Anuradha, Mondal Santosh Kumar
Department of Pathology, Bankura Sammilani Medical College, Bankura, West Bengal, India.
J Cancer Res Ther. 2015 Oct-Dec;11(4):1028. doi: 10.4103/0973-1482.153664.
Desmoplastic small round cell tumor (DSRCT) is rare and highly malignant neoplasm. DSRCT affects usually young males but can occur in adults also. Intra-abdominal pelvic region is the preferred site. Though confirmed by histology, immunohistochemistry (IHC) plays a key role in diagnosis. IHC profile is characteristic, it shows simultaneous expression of epithelial (epithelial membrane antigen (EMA) and cytokeratin (CK)), muscular (desmin), and neural (neuron-specific enolase) markers. Many cases of DSRCT are diagnosed as poorly differentiated carcinoma due to lack of proper panel of IHC. It is difficult to predict if there has been a true increase in incidence. Prognosis is uncertain in such an aggressive neoplasm as chemotherapy (CT) or radiotherapy (RT) shows various outcomes. Here in; we report four cases, all of which showed diagnostic dilemma and uncertain prognosis.
促结缔组织增生性小圆细胞肿瘤(DSRCT)是一种罕见的高度恶性肿瘤。DSRCT通常影响年轻男性,但也可发生于成年人。腹腔盆腔区域是其好发部位。虽然通过组织学确诊,但免疫组织化学(IHC)在诊断中起关键作用。IHC特征性表现为上皮(上皮膜抗原(EMA)和细胞角蛋白(CK))、肌肉(结蛋白)和神经(神经元特异性烯醇化酶)标志物的同时表达。由于缺乏合适的IHC检测组合,许多DSRCT病例被诊断为低分化癌。很难预测其发病率是否真的有所增加。在这种侵袭性肿瘤中,化疗(CT)或放疗(RT)的结果各异,预后不确定。在此,我们报告4例病例,所有病例均表现出诊断困境和预后不确定。